EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early‐Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B

Tomer Poleg, Noam Hadar, Eyal Kristal, Nicola Y Roberts, Vadim Dolgin, Ilana Aminov, Amit Safran, Nadav Agam, Matan Jean, Ofek Freund, Eamonn G Sheridan, James A Poulter und 10 weitere

Movement Disorders · 2025

DOI: 10.1002/mds.30249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Tomer Poleg und 21 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel. Hauptthemen laut MEDLINE: Cyclic Nucleotide Phosphodiesterases, Type 1, Movement Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Institute for Health and Care Research - Biomedical Research Centre, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breakdown of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in basal ganglia cells through hydrolysis of diesteric bonds, primarily by PDE10A and PDE1B, is essential for normal human movement. While biallelic loss‐of‐function variants in PDE10A are known to cause hyperkinetic movement disorders, the role of PDE1B in human disease has not been characterized.

Objectives

We aimed to define the phenotypic and molecular characteristics of a novel autosomal recessive disorder caused by biallelic PDE1B variants.

Methods

Clinical phenotyping by senior geneticists and neurologists, followed by whole exome sequencing, segregation analysis (Sanger sequencing), and molecular studies, including mini‐gene splicing assays and protein studies in transfected HEK293 cells.

Results

Seven affected individuals from five unrelated pedigrees presented with an apparently autosomal recessive disorder characterized by hypotonia in infancy, progressing to ataxia and dystonia in early childhood, with developmental delay and intellectual disability. Biallelic PDE1B variants were identified in all affected individuals: three truncating (p.Q45*, p.Q86*, p.S298Afs*6) and three splicing variants (c.594 + 2 T>G, c.735 + 5G>A, c.837‐1G>C). Functional studies confirmed that the truncating variants caused loss of the catalytic domain, resulting in truncated or absent functional protein. Splicing variants led to exon skipping, frameshifts, and catalytic domain disruption. These findings establish a causative link between biallelic PDE1B variants and the observed clinical phenotype.

Conclusions

Biallelic loss‐of‐function variants in PDE1B underlie a novel early‐onset movement disorder resembling the phenotype associated with PDE10A deficiency. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclic Nucleotide Phosphodiesterases, Type 1Movement DisordersHumansMaleFemalePedigreeChild, PreschoolChildAdultDevelopmental DisabilitiesPhenotypeHEK293 CellsAdolescentExome Sequencing

Stichwörter der Autor:innen

PDE1Bearly onsetexome sequencingmovement disorderphosphodiesterase

Substanzen

Cyclic Nucleotide Phosphodiesterases, Type 1

Autor:innen und Institutionen

  • Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Pediatric Ambulatory Unit, Soroka University Medical Center, Be'er Sheva, Israel.
  • Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • HudsonAlpha Institute of Biotechnology, Huntsville, Alabama, USA.
  • Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Movement Disorders Program, Neuroscience Centre, King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh, Saudi Arabia.

ORCID-Profile: Henry Houlden, Ohad S Birk

Förderung

  • Medical Research Council
  • National Institute for Health and Care Research - Biomedical Research Centre
  • NCI NIH HHS
  • NHGRI NIH HHS
  • Sir Jules Thorn Charitable Trust
  • Israel Science Foundation
  • National Institute Health Research/Medical Research Council Clinical Academic Research Partnership award
  • Wellcome Trust

Zitieren

APA

Poleg, T., Hadar, N., Kristal, E., Roberts, N. Y., Dolgin, V., Aminov, I., Safran, A., Agam, N., Jean, M., Freund, O., Sheridan, E. G., Poulter, J. A., Thompson, M. L., Algoos, Y., Al-Qahtani, S., AlAbdi, L., Maddirevula, S., Hartill, V., Houlden, H., …, & Birk, O. S. (2025). Early‐Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B. Movement Disorders. https://doi.org/10.1002/mds.30249

Vancouver

Poleg T, Hadar N, Kristal E, Roberts NY, Dolgin V, Aminov I, et al. Early‐Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B. Movement Disorders. 2025. doi:10.1002/mds.30249

BibTeX
@article{Poleg2025,
  author = {Poleg, Tomer and Hadar, Noam and Kristal, Eyal and Roberts, Nicola Y and Dolgin, Vadim and Aminov, Ilana and Safran, Amit and Agam, Nadav and Jean, Matan and Freund, Ofek and Sheridan, Eamonn G and Poulter, James A and Thompson, Michelle L and Algoos, Yusra and Al-Qahtani, Salma and AlAbdi, Lama and Maddirevula, Sateesh and Hartill, Verity and Houlden, Henry and Maroofian, Reza and Nahum, Amit and Birk, Ohad S},
  title = {Early‐Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.30249}
}
Kostenlos starten →